(Date:11/24/2009)... Ambassador to also Visit Detroit , ... ,Who: David Appia, French Ambassador for Internat...st in France Agency, , , , ,What: Ambassador Appi...t pro-business initiatives adopted by France to fu...andscape for innovation and development., , ,When:...
(Date:11/24/2009)...ov.24/PRNewswire-FirstCall/--Sigma-AldrichCorporat...nferenceonTuesday,December1stat1:45PMGMTinLondon,7...broadcastovertheInternetavailableat http://inve ...e"Webcast"icontoaccessthisfile. ,, AboutSigma...ghTechnologycompany.Itschemicalandbiochemicalprodu...
(Date:11/24/2009)...ov.24/PRNewswire-Asia/--ShanghaiBiolaxyannouncedth...approvedthe,investigationalnewdrugapplication(IND)...linformulationtotreatdiabetes.ThisIND,approvalallo..., Diabetesisadisordercharacteristicofhighbloodg...softenresultinseveremicro-and,macro-vasculardiseas...
(Date:11/24/2009)...ember24/PRNewswire-FirstCall/--Shireplc(LSE:SHP,N...company,today,announcedthatithassubmittedaMAAtothe...mpany,senzymereplacementtherapyindevelopment,forth...eting,applicationforvelaglucerasealfathathasbeensu...ndCanada. , Basedonaglobalsupplyshortageofthe...
Breaking Biology Technology:Biolaxy Secures IND Approval for Oral Insulin 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3...rican Academy of Ophthalmology,(AAO) 2008 Annual M...of,premium nutraceuticals for eye health, today an...y supplement to support the visual and overall,hea... -- 8% of the population and nearly 25% of those 6...n added to the 57 million,Americans with pre-diabe...
...Under Consideration, ROCKVILLE, Md., Nov. 10 Ent...rmaceutical company developing,therapeutics for th...oday,announced that it has met the primary endpoin... 1/2 study of MKC-1 in combination with pemetrexed...s., (Logo: http://www.newscom.com/cgi-bin/prnh/2...
...Xinhua-PRNewswire/ -- Simcere Pharmaceutical,Group...r of branded generic,pharmaceuticals and innovativ...ng China market, announced today its participation...mit 2008. The conference will be held at,the Manda...Simcere,s chief financial officer, Frank Zhigang Z...
Other Biology Technology:ScienceBased Health Announces the Launch of Diavis(TM), a New Dietary Supplement for the 81 Million Americans With or at Risk for Diabetes 2EntreMed's MKC-1 Meets Primary Efficacy Endpoint in Non-Small Cell Lung Cancer Clinical Trial 2EntreMed's MKC-1 Meets Primary Efficacy Endpoint in Non-Small Cell Lung Cancer Clinical Trial 3Simcere Pharmaceutical Group to Participate in Morgan Stanley Seventh Annual Asia Pacific Summit 2008 2Chicken Anti-Human PFM8 Polyclonal Antibody, Unconjugated from ProSci, Inc
Rabbit Anti-NCoR2 Polyclonal Antibody, Unconjugated from Abcam
Goat Anti-PITPN Antibody, Unconjugated from Raybiotech, Inc.
Goat Anti-Human Nebraska Calf Diarrhea Virus Polyclonal Antibody, FITC Conjugated from Abcam
Biology Products: